Stocks / NASDAQ / Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc.

Our Opinion

Cidara Therapeutics, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

In the following press release company mentioned its usage of animals for testing drugs.

Jeffrey Stein, Ph.D., president and chief executive officer of Cidara said, “We are obviously disappointed with these results, which did not demonstrate the highly potent antifungal properties of CD101 against Candida we saw in preclinical animal models of VVC.” Read the full article.

Company Description

Cidara Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of anti-infectives for the treatment of fungal infections. Is portfolio includes CD101 IV, CD101 Topical, and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA. [Source: MarketWatch]

Company Website: